Search

everythinglearnresearchcommunity

for

Search:↓

TrichoSol™ effectively stabilizes various hair treatment ingredients for different durations.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Posaconazole is a promising new treatment for toenail fungus.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Multiple treatment comparison meta-analyses help doctors make better decisions by comparing different interventions.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Some medications can help increase sexual desire and function in women.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

TM-β-CD improves finasteride's solubility and delivery, while β-CD offers better long-term release.